Nodal metastasis risk in endometrioid endometrial cancer.
about
Current Issues in the Diagnosis and Treatment of Endometrial CarcinomaProspective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancerLymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life.The effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients.Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancerSentinel Lymph Node Mapping in Endometrial Cancer: An Update.The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer.Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients?Indications and techniques for robotic pelvic and para-aortic lymphadenectomy in gynecologic oncology.The role of pathology in the management of patients with endometrial carcinoma.Predictors for lymph nodes involvement in low risk endometrial cancer.Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis.Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer.Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection.Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.Intraoperative Pathologic Consultation on Hysterectomy Specimens for Endometrial Cancer: An Assessment of the Accuracy of Frozen Sections, "Gross-Only" Evaluations, and Obtaining Random Sections of a Grossly "Normal" Endometrium.The prognostic significance of preoperative serum cancer antigen 15-3 levels in endometrial carcinomas.Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer.
P2860
Q26768659-9D6BD444-5D88-4502-8ADA-1FF8827E20EDQ30634344-6B4FCE1E-3CB7-40A7-91C4-687640105873Q34724809-30C26CCE-C8BA-4206-895E-DB166C87CF2BQ35954346-69D8E6D1-E470-4BFF-8523-0F7B4B905E5FQ35984477-2C17D4DF-51CB-4A6C-AF0C-F97B55E2DB50Q36470869-609082D7-5F82-4C16-A57C-7DC155AE5B63Q36788300-C7C94706-D580-46BA-9139-772F795BC288Q37248787-399A062D-CE59-4E7B-AE7E-467166D7F982Q37436131-0A9913C3-8CE6-4CC6-80A2-BBC04D41DB78Q37559040-D6027429-AFC5-4DF0-98FD-05EAA74D5B05Q37700116-B41161F5-0291-4707-983F-91ABC5CF1881Q38178732-DC38EF09-1216-4DD9-97BE-784D8948C93EQ38569623-EACC9AD5-47D0-4F86-A8ED-44AA641F397EQ38686652-27FEEBBF-A93F-41F6-A49E-1AA9BBB8D946Q38879230-B5BB29BB-CAE9-4C8A-80D6-0AD266BE0E3DQ39402072-7D0BD0D3-DD5E-4927-938D-C6A4EC8C58A0Q40958885-8C597B66-0171-44C4-B942-107F95A99FAFQ40964055-3E741D7F-EF76-4D69-8128-3D9710635580Q41726020-80185491-47B5-4465-B8A3-3763094A60BBQ42643685-6FD1FF36-157D-4657-B4FA-DB3F54BE2D6BQ43111645-6571D33E-921F-48E1-AA57-2613C8B0D0E5Q44515920-37F92D8A-54F7-4E2A-AE7F-3F05A56F0726Q46785812-ECE82BE1-F9B9-4EE2-8B5A-2B292F03AB51Q47223775-85470C4B-7E13-4B72-8847-988800A5F1E8Q47415184-6E8469B2-47B4-4340-BE99-B2E8843BE93AQ47892392-976C7FA0-72E7-4B4E-BA7A-9064902FA891Q48176485-9E254517-60DE-4185-8618-9FF1CA4B2727Q51756195-45B13566-A7C8-4D33-9C6F-E5D7AF3DD47F
P2860
Nodal metastasis risk in endometrioid endometrial cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nodal metastasis risk in endometrioid endometrial cancer.
@ast
Nodal metastasis risk in endometrioid endometrial cancer.
@en
Nodal metastasis risk in endometrioid endometrial cancer.
@nl
type
label
Nodal metastasis risk in endometrioid endometrial cancer.
@ast
Nodal metastasis risk in endometrioid endometrial cancer.
@en
Nodal metastasis risk in endometrioid endometrial cancer.
@nl
prefLabel
Nodal metastasis risk in endometrioid endometrial cancer.
@ast
Nodal metastasis risk in endometrioid endometrial cancer.
@en
Nodal metastasis risk in endometrioid endometrial cancer.
@nl
P2093
P2860
P1476
Nodal metastasis risk in endometrioid endometrial cancer.
@en
P2093
Daniel S Metzinger
Gynecologic Oncology Group
James Java
Joan L Walker
Lynn P Parker
Michael R Milam
Robert L Coleman
P2860
P304
P356
10.1097/AOG.0B013E318240DE51
P407
P433
P577
2012-02-01T00:00:00Z